These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 22000073)
1. A stability indicating simultaneous dual wavelength UV-HPLC method for the determination of potential impurities in fampridine active pharmaceutical ingredient. Thomas S; Shandilya S; Bharti A; Agarwal A J Pharm Biomed Anal; 2012 Jan; 58():136-40. PubMed ID: 22000073 [TBL] [Abstract][Full Text] [Related]
2. Quantification of potential impurities by a stability indicating UV-HPLC method in niacinamide active pharmaceutical ingredient. Thomas S; Bharti A; Tharpa K; Agarwal A J Pharm Biomed Anal; 2012 Feb; 60():86-90. PubMed ID: 22115882 [TBL] [Abstract][Full Text] [Related]
3. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities. Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation. Reddy PS; Sudhakar Babu K; Kumar N J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002 [TBL] [Abstract][Full Text] [Related]
5. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation. Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution. Kasawar GB; Farooqui M J Pharm Biomed Anal; 2010 May; 52(1):19-29. PubMed ID: 20045275 [TBL] [Abstract][Full Text] [Related]
7. Stability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms. Nageswari A; Reddy KV; Mukkanti K J Pharm Biomed Anal; 2012 Jul; 66():109-15. PubMed ID: 22502910 [TBL] [Abstract][Full Text] [Related]
8. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS. Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334 [TBL] [Abstract][Full Text] [Related]
9. Determination of duloxetine hydrochloride in the presence of process and degradation impurities by a validated stability-indicating RP-LC method. Raman NV; Harikrishna KA; Prasad AV; Reddy KR; Ramakrishna K J Pharm Biomed Anal; 2010 Mar; 51(4):994-7. PubMed ID: 20005658 [TBL] [Abstract][Full Text] [Related]
10. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms. Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890 [TBL] [Abstract][Full Text] [Related]
11. A validated stability-indicating normal phase LC method for clopidogrel bisulfate and its impurities in bulk drug and pharmaceutical dosage form. Durga Rao D; Kalyanaraman L; Sait SS; Venkata Rao P J Pharm Biomed Anal; 2010 May; 52(1):160-5. PubMed ID: 20074888 [TBL] [Abstract][Full Text] [Related]
12. Stability-indicating HPLC method for the determination of darunavir ethanolate. Reddy BV; Jyothi G; Reddy BS; Raman NV; Reddy KS; Rambabu C J Chromatogr Sci; 2013; 51(5):471-6. PubMed ID: 23097581 [TBL] [Abstract][Full Text] [Related]
13. A stability-indicating HPLC method for the determination of bazedoxifene acetate and its related substances in active pharmaceutical ingredient. Visweswara Rao K; Reddy KP; Kumari KS; Srinivas M J Chromatogr Sci; 2013 Mar; 51(3):215-21. PubMed ID: 22865837 [TBL] [Abstract][Full Text] [Related]
14. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant. Lalitha Devi M; Chandrasekhar KB J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800 [TBL] [Abstract][Full Text] [Related]
15. A stability-indicating reversed-phase high performance liquid chromatography method for simultaneous assay of two corticosteroids and estimation of their related compounds in a pharmaceutical injectable formulation. Lu J; Wei Y; Rustum AM J Chromatogr A; 2010 Oct; 1217(44):6932-41. PubMed ID: 20855075 [TBL] [Abstract][Full Text] [Related]
16. A validated stability indicating ultra performance liquid chromatographic method for determination of impurities in Esomeprazole magnesium gastro resistant tablets. Nalwade SU; Reddy VR; Rao DD; Morisetti NK J Pharm Biomed Anal; 2012 Jan; 57():109-14. PubMed ID: 21920688 [TBL] [Abstract][Full Text] [Related]
17. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities. Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505 [TBL] [Abstract][Full Text] [Related]
18. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form. Sharma N; Rao SS; Reddy AM J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819 [TBL] [Abstract][Full Text] [Related]
19. A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product. Malati V; Reddy AR; Mukkanti K; Suryanarayana MV Talanta; 2012 Aug; 97():563-73. PubMed ID: 22841123 [TBL] [Abstract][Full Text] [Related]
20. Quantification and structural elucidation of potential impurities in agomelatine active pharmaceutical ingredient. Liu Y; Chen L; Ji Y J Pharm Biomed Anal; 2013; 81-82():193-201. PubMed ID: 23666256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]